Eliem Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.81 | $223.86 M | -2.51 | 58 | $0 |
ADAG
Adagene Inc. |
$2.05 | $131.46 M | -6.77 | 174 | $18.11 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.00 | $56.28 M | -5.86 | 2 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.27 | $60.55 M | -0.81 | 41 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.53 | $597.48 M | -6.84 | 51 | $0 |
CSBR
Champions Oncology, Inc. |
$7.48 | $62.53 M | -6.39 | 210 | $50.16 M |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
HCWB
HCW Biologics Inc. |
$0.44 | $39.35 M | -1.37 | 45 | $2.84 M |
IPSC
Century Therapeutics, Inc. |
$1.09 | $244.54 M | -1.32 | 152 | $2.24 M |
MNOV
MediciNova, Inc. |
$2.15 | $67.19 M | -8.06 | 13 | $1.00 M |
MOLN
Molecular Partners AG |
$5.08 | $135.05 M | -2.03 | 167 | $7.04 M |
PEPG
PepGen Inc. |
$3.63 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$20.00 | $843.31 M | -5.8 | 83 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.50 | $85.40 M | -1.26 | 63 | $0 |
PRDS
Pardes Biosciences, Inc. |
$2.18 | $135.19 M | -1.7 | 57 | $0 |
RZLT
Rezolute, Inc. |
$4.39 | $229.57 M | -5.02 | 59 | $0 |
STTK
Shattuck Labs, Inc. |
$1.14 | $333.81 M | -3.64 | 75 | $1.66 M |